Follow The Filings

ACU Acme United

Acme United earnings company data as of 7:44 PM ET 10/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 27 Oct EPS 0.71 — —
Rev — — —

Insider trades

Open-market buys and sales by ACU's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ACU insider trades
  • None no insider bought on the open market
  • $1.7M sold by 4 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Richmond Y Holden Jr. Director
    Sale
    $21K 341 shares at $62.01 2% of stake
    Traded Oct 9 Filed Oct 22
  2. Brian S Olschan COO
    Sale
    $449K 7,308 shares at $61.48 15% of stake
    Traded Aug 18 Filed Aug 19
  3. Brian Barker Director
    Sale
    $231K 3,821 shares at $60.50 100% of stake
    Traded Aug 13 Filed Aug 17
  4. Brian S Olschan COO
    Sale
    $616K 10,909 shares at $56.51 21% of stake
    Traded Aug 3–12 Filed Aug 12
  5. Rex Lynn Davidson Director
    Sale
    $208K 3,684 shares at $56.48 100% of stake
    Traded Aug 10 Filed Aug 11
  6. Brian S Olschan COO
    Sale
    $203K 4,833 shares at $42.00 11% of stake
    Traded May 28 Filed May 29

Also filed in the last 12 months, not counted as buying or selling: 13 option exercises, 10 share withholdings for taxes, 3 sales back to the company, and 2 gifts.

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
8-K 1.01,1.02,2.03,9.01
10-Q
8-K 5.07
8-K 2.02,9.01
SCHEDULE 13G/A —
DEF 14A
10-K
8-K 2.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 1.01,2.01,9.01
10-Q

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.